Fiche publication
Date publication
mars 2010
Auteurs
Membres identifiés du Cancéropôle Est :
Pr JACQMIN Didier
Tous les auteurs :
Mejean A, Guy L, Jacqmin D, Joly F, Negrier S, Pignot G
Lien Pubmed
Résumé
Antiangiogenic treatment initiation justifies a clinical and biological pretherapeutic assessment and a close follow-up of side effects according to each drug. Because of potential healing complications, a deadline of 4 weeks after surgery is recommended before starting antiangiogenic treatment. The optimal sequence and the potential role of neo-adjuvant therapies remain to define. In the absence of prospective data, nephrectomy is still recommended in renal cell carcinoma management. (C) 2010 Published by Elsevier Masson
Référence
Prog Urol. 2010 Mar;20 Suppl 1:S16-9
